HDAC1 and glioblastoma: In addition, based on a high-throughput drug screen involving gamitrinib (G-TPP), we discovered that blockage of TRAP1 along with HDAC1/2 is synthetically lethal in GBM model systems, which was confirmed in vivo as well [75,76].